Adagene Inc (ADAG)
2.18
-0.08
(-3.54%)
USD |
NASDAQ |
Nov 22, 16:00
2.18
0.00 (0.00%)
After-Hours: 18:29
Adagene Shareholders Equity (Quarterly): 56.59M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 56.59M |
| December 31, 2023 | 70.56M |
| June 30, 2023 | 82.79M |
| December 31, 2022 | 83.09M |
| June 30, 2022 | 112.68M |
| Date | Value |
|---|---|
| December 31, 2021 | 156.56M |
| June 30, 2021 | 186.22M |
| December 31, 2020 | -89.39M |
| September 30, 2020 | 75.47M |
| December 31, 2019 | -57.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-89.39M
Minimum
Dec 2020
186.22M
Maximum
Jun 2021
67.76M
Average
79.13M
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.649B |
| CASI Pharmaceuticals Inc | 13.85M |
| Zai Lab Ltd | 667.67M |
| China SXT Pharmaceuticals Inc | 13.93M |
| LakeShore Biopharma Co Ltd | 76.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.78M |
| Total Liabilities (Quarterly) | 44.19M |